Advertisement

Hyaluronidase Injection in the Vocal Folds for Vocal Hemorrhage, Reinke Edema, and Hyaluronic Acid Overinjection: A Novel Application in the Larynx

  • Peak Woo
    Correspondence
    Address correspondence and reprint requests to Peak Woo, Department of Otolaryngology Head and Neck Surgery, Icahn School of Medicine, 300 Central Park West 1H, New York, NY 10024.
    Affiliations
    Department of Otolaryngology Head and Neck Surgery, Icahn School of Medicine, New York, New York
    Search for articles by this author
Published:September 01, 2017DOI:https://doi.org/10.1016/j.jvoice.2017.07.004

      Summary

      Hyaluronidase (HAase) injection into the vocal folds is an off-label use of an enzyme for liquefaction of hyaluronic acid (HA). HAase injection was performed in 14 cases in 13 patients. Office and operative injections of HAase were performed. The indications were five cases of overinjection of HA, six cases of Reinke edema and polypoid corditis, and three cases of acute vocal hemorrhage with early fusiform polyp formation. All the patients tolerated the HAase without complications. Significant voice improvements were noted between pre- and postinjection procedures as evaluated by a self-rating of voice by the Voice Handicap Index-10. A marked decrement in the mass on the side of the injection of HAase was noted in all groups successfully injected upon viewing by videostroboscopy. HAase prevented an additional operative phonosurgery in 10 patients. In conclusion, HAase injection can be used in the vocal folds with good effect in patients. The indications are polypoid corditis with overproduction of HA, acute vocal hemorrhage, and correction of iatrogenic HA overinjection.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Voice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stern R.
        • Jedrzejas M.J.
        Hyaluronidases: their genomics, structures, and mechanisms of action.
        Chem Rev. 2006; 106: 818-839
        • Goolsby T.V.
        • Lombardo F.A.
        Extravasation of chemotherapeutic agents: prevention and treatment.
        Semin Oncol. 2006; 33: 139-143
        • Dunn A.L.
        • Heavner J.E.
        • Racz G.
        • et al.
        Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management.
        Expert Opin Biol Ther. 2010; 10: 127-131
        • Cavallini M.
        • Gazzola R.
        • Metalla M.
        • et al.
        The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers.
        Aesthet Surg J. 2013; 33: 1167-1174
        • Chan R.W.
        • Gray S.D.
        • Titze I.R.
        The importance of hyaluronic acid in vocal fold biomechanics.
        Otolaryngol Head Neck Surg. 2001; 124: 607-614
        • Tateya I.
        • Tateya T.
        • Watanuki M.
        • et al.
        Homeostasis of hyaluronic acid in normal and scarred vocal folds.
        J Voice. 2015; 29: 133-139
        • Thibeault S.L.
        • Klemuk S.A.
        • Chen X.
        • et al.
        In vivo engineering of the vocal fold ECM with injectable HA hydrogels-late effects on tissue repair and biomechanics in a rabbit model.
        J Voice. 2011; 25: 249-253
        • Hertegard S.
        • Hallen L.
        • Laurent C.
        • et al.
        Cross-linked hyaluronan used as augmentation substance for treatment of glottal insufficiency: safety aspects and vocal fold function.
        Laryngoscope. 2002; 112: 2211-2219
        • Haneke E.
        Managing complications of fillers: rare and not-so-rare.
        Journal of cutaneous and aesthetic surgery. 2015; 8: 198-210
        • Dikkers F.G.
        • Nikkels P.G.
        Lamina propria of the mucosa of benign lesions of the vocal folds.
        Laryngoscope. 1999; 109: 1684-1689
        • Lennon F.E.
        • Singleton P.A.
        Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.
        Am J Physiol Lung Cell Mol Physiol. 2011; 301: L137-L147
        • Thibeault S.L.
        Advances in our understanding of the Reinke space.
        Curr Opin Otolaryngol Head Neck Surg. 2005; 13: 148-151
        • Lebl M.D.
        • Martins J.R.
        • Nader H.B.
        • et al.
        Concentration and distribution of hyaluronic acid in human vocal folds.
        Laryngoscope. 2007; 117: 595-599
        • Girish K.S.
        • Kemparaju K.
        The magic glue hyaluronan and its eraser hyaluronidase: a biological overview.
        Life Sci. 2007; 80: 1921-1943
        • Rousseau B.
        • Hirano S.
        • Chan R.W.
        • et al.
        Characterization of chronic vocal fold scarring in a rabbit model.
        J Voice. 2004; 18: 116-124
        • Finck C.
        • Lefebvre P.
        Implantation of esterified hyaluronic acid in microdissected Reinke's space after vocal fold microsurgery: first clinical experiences.
        Laryngoscope. 2005; 115: 1841-1847
        • Rousseau B.
        • Tateya I.
        • Lim X.
        • et al.
        Investigation of anti-hyaluronidase treatment on vocal fold wound healing.
        J Voice. 2006; 20: 443-451
        • Goldberg R.A.
        • Fiaschetti D.
        Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections.
        Ophthal Plast Reconstr Surg. 2006; 22 (discussion 341-333): 335-341
        • Rzany B.
        • Becker-Wegerich P.
        • Bachmann F.
        • et al.
        Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use.
        J Cosmet Dermatol. 2009; 8: 317-323
        • Narayanan R.
        • Kuppermann B.D.
        Hyaluronidase for pharmacologic vitreolysis.
        Dev Ophthalmol. 2009; 44: 20-25